Genprex, Inc. (GNPX)
NASDAQ · Healthcare
Genprex, Inc. Shareholder Equity 2016–2024
Genprex, Inc. annual shareholder equity history from 2016 to 2024. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Genprex, Inc. shareholder equity as of December 31, 2024: 1.6M, a 78.15% decrease year-over-year.
- Genprex, Inc. shareholder equity for 2024 were 1.6M, a 78.15% decrease from 2023.
- Genprex, Inc. shareholder equity for 2023 were 7.4M, a 66.70% decrease from 2022.
- Genprex, Inc. shareholder equity for 2022 were 22.3M, a 46.04% decrease from 2021.
- Genprex, Inc. shareholder equity for 2021 were 41.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Genprex, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2024 | $2 |
| 2023 | $7 |
| 2022 | $22 |
| 2021 | $41 |
| 2020 | $31 |
| 2018 | $9 |
| 2017 | $0 |
| 2016 | $2 |
Genprex, Inc. Shareholder Equity — FAQ
Genprex, Inc. (GNPX) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GNPX's shareholder equity history?
The chart and table above show Genprex, Inc.'s shareholder equity by year and by quarter, including the growth rate.